Genetics, Treatment, and New Technologies of Hormone Receptor-Positive Breast Cancer

Genetics, Treatment, and New Technologies of Hormone Receptor-Positive Breast Cancer

The current molecular classification divides breast cancer into four major subtypes, including luminal A, luminal B, HER2-positive, and basal-like, based on receptor gene expression profiling. Luminal A and luminal B are hormone receptor (HR, estrogen, and/or progesterone receptor)-positive and are...

Full description

Bibliographic Details
Main Authors: William Sebastian, Lauren Forchette, Kelsey Donoughe, Yibei Lun, Anisha Verma, Tuoen Liu
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Cancers
Subjects:
breast cancer
hormone receptor
estrogen receptor
endocrine therapy
drug treatment
genetics
Online Access:https://www.mdpi.com/2072-6694/15/4/1303

Internet

https://www.mdpi.com/2072-6694/15/4/1303

Similar Items